Answer
Pegaspargase (Oncaspar) with other chemotherapy can cause somnolence, confusion, dizziness, fainting or seizures, and patients should not drive or operate machines if these or other adverse reactions impair their ability.
Sources for this answer
- Oncaspar 750 U/ml powder for solution for injection/infusionServier Laboratories Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 8Document updated
Sources checked